Publication of the Calmux® study in the preventive treatment of migraine.

 

Clinical Neurology and Neurosurgery.

 

 

The prestigious scientific journal Clinical neurology and neurosurgery publishes in its last issue the scientific study of neurologist Dr. Ayoze González, which is entitled "Palmitaylethanolamide-Based nutraceutical calmux® in Preventive Treatment of Migraine" (Callmux® Palmita -Palamide -based nutraceutical in the preventive treatment of migraine).

 

 

It is an open prospective experimental study in which the impact of Calmux® (nutritional complement based on PEA, Boswellia Serrata, Scutellaria Baicalensis, Harpagophytum, Vitamin B1, B2, B3, B6 and Vitamin E) in the preventive treatment) in the preventive treatment) in the preventive treatment) in the preventive treatment From the migraine it was developed for 6 months uninterrupted for 2021, pouring interesting results that open a door to the use of natural ingredients to improve the quality of life of people suffering from this disease.

 

The study conclusions revealed that taking two capsules a day from Calmux®:

 

- Reduce migraine crises by 50%.

- Reduces the intensity of migraine crises.

- Improves the quality of life of people suffering from migraines.

- Reduce the consumption of drugs for migraine.

 

 

This pilot trial with a small number of patients raises an alternative to conventional drugs in the approach of migraine, a pathology that affects 1 in 10 people in the world, constituting one of the 20 most frequent causes of disability. Dr. González concludes in the article that Pea's nutraceutics, such as Calmux®, could be useful for migraine prevention. Although more studies are necessary to consolidate the results we can say that a new approach to the treatment of this disease is opened.

 

Know more about Calmux®

WhatsApp